| ¿µ¹® | nuclear medicine | ÇÑ±Û | ÇÙÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼ºÀ» ¶ì´Â ÇÙ¹°ÁúÀ» ÀÌ¿ëÇÏ¿© ÀÇÇп¡ ÀÀ¿ëÇÏ´Â Çй®. ´ë°³ ÀÎü¿¡ Å« ÇØ°¡ ¾ø´Â ¹æ»ç¼±¹°ÁúÀ» »ç¿ëÇϸç, ¹Ý°¨±â°¡ ª¾Æ »ç¿ëÈÄ¿¡µµ Å« ÇØ°¡ ¾ø´Ù. ÀÌ·± ÇÙÀÇÇÐÀû ¹°ÁúÀ» ÀÌ¿ëÇÑ ÇÙÀÇÇÐÀû Áø´ÜÀÇ °¡Àå Å« ÀåÁ¡Àº »ýü³»¿¡¼ ÀϾ´Â ±× ±â°üÀÇ ½ÇÁ¦ÀûÀÎ ±â´ÉÀ» ¾Ë¾Æº¼ ¼ö ÀÖ´Ù´Â µ¥ ÀÖ´Ù. ÈçÈ÷ Á¢ÇÏ´Â X-¼±À» ÀÌ¿ëÇÑ Áø´Ü¹æ¹ýÀº ´ÜÁö ±× ¼ø°£¸¸ÀÇ ¿µ»óÀ» Á¢ÇÏ¿© ½ÇÁ¦·Î º¸ÀÌ´Â ºÎÀ§°¡ ¾ó¸¶³ª ±â´ÉÀ» ¼öÇàÇÏ´ÂÁö ¾Ë ¼ö ¾ø´Â ´ÜÁ¡ÀÌ ÀÖÀ¸³ª, ÇÙÀÇÇп¡¼´Â ½ÇÁ¦ÀûÀÎ ±â´ÉÀÇ Á¤µµ¿¡ µû¶ó ¿µ»óÀÌ ³ª¿À°Ô µÇ¹Ç·Î ±â´ÉÆÇº°¿¡ ¾ÆÁÖ À¯¸®ÇÏ´Ù. ÇÏÁö¸¸, Á¤È®ÇÑ ÆÇº°·ÂÀÌ ÀÖ´Â ¿µ»óÀ» ¾ò±â¿¡´Â ºÎÁ·ÇÏ´Ù. ¶ÇÇÑ ÇÙÀÇÇÐÀº Áø´Ü¿ÜÀÇ Ä¡·á¿¡µµ »ç¿ëµÇ´Âµ¥, ¿¹¸¦ µé¾î °©»ó»ùÁ¾¾çÀÇ °æ¿ì ¿©·¯ °÷¿¡ ÀÌ¹Ì ÀüÀ̰¡ µÇ¾î ÀÖÀ» °æ¿ì ¹æ»ç¼±ÇÙÁ¾À» ÀÌ¿ëÇÏ¿© ´Ù¸¥ °÷¿¡ Å« ºÎÀÛ¿ë¾øÀÌ Ä¡·á°¡ °¡´ÉÇÏ´Ù. |
||
| ¿µ¹® | nuclear magnetic resonance(NMR) | ÇÑ±Û | ÇÙÀÚ±â°ø¸í |
|---|---|---|---|
| ¼³¸í | ´Ù¸¥ ¸»·Î MRI=Magnetic Resonance Imaging ÀÚ±â°ø¸í¿µ»óÀ̶ó°íµµ ÇÑ´Ù. ÀÎüÀÇ Àå±â³ª, º´ÀûÀÎ ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇÏ´Â ¹æ»ç¼±ÇÐÀûÀÎ °Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í ÀÖ´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT=computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× ÇØ»óµµ°¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é(plane)¿¡¼ »ç¶÷À» ´ÜÃþ½ÃÄÑ º¼ ¼ö ÀÖ´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀÚÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í ÀÖ´Â ÁßȯÀÚ µî¿¡¼´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ¶³¾îÁö´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. |
||
| NM | near-miss; neomycin; neuromedin; neuromuscular; neutrophil migration; nictitating membrane; nitrogen... |
|---|---|
| ANA | Anti-Nuclear Antibody |
| Anti-ENA | Anti-Extractable Nuclear Antigens |
| EBNA | Epstain-Barr Nuclear Antigen |
| NMR | Nuclear Magnetic Resonance; ÇÙÀڱ⠰ø¸í¼ú |
| nuclear VV | nuclear volume |
|---|---|
| (1)H-NMR | 1)H-nuclear magnetic resonance |
| NMR | 1)H-nuclear magnetic resonance |
| (13)C NMR | 13)C nuclear magnetic resonance |
| NMR | 13)C-nuclear magnetic resonance |
| geometric isomerism | A form of isomerism displayed by unsaturated or ring compounds where free rotation about a bond (usually a carbon-carbon bond) is restricted; e.g., the isomerism of a cis-or trans-compound as in oleic acid and elaidic acid. Compare: cis-, entgegen, trans-, zusammen. (05 Mar 2000) |
|---|---|
| stereochemical isomerism | The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (12 Dec 1998) |
| structural isomerism | Isomerism involving the same atoms in different arrangements; e.g., butyric acids, leucine and isoleucine, glucose and fructose. (05 Mar 2000) |
| isomerism | A condition in which several chemical compounds have the same molecular formula (have the same number and type of atoms) but, because those atomsare arranged differently in each, they all have different chemical properties. (09 Oct 1997) |
| optical isomerism | Stereoisomerism involving the arrangement of substituents about an asymmetric atom or atoms (usually carbon) so that there is a difference in the behaviour of the various isomers with regard to the extent of their rotation of the plane of polarised light. Compare: stereoisomerism. (05 Mar 2000) |
| receptors, cytoplasmic and nuclear | Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands. (12 Dec 1998) |
| Remak's nuclear division | <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa. (18 Nov 1997) |
| Pelger-Huet nuclear anomaly | Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance. (05 Mar 2000) |
| ribonucleoproteins, small nuclear | Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end. (12 Dec 1998) |
| RNA, heterogeneous nuclear | Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesised and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnrna hybridises with nuclear DNA rather than with mRNA. (12 Dec 1998) |
| RNA, nuclear | RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm. (12 Dec 1998) |
| RNA, small nuclear | Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus. (12 Dec 1998) |
| rod nuclear cell | <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand. (18 Nov 1997) |
| cistern of nuclear envelope | The space between the internal and external membranes of the nuclear envelope; may be continuous in places with cisterns of the endoplasmic reticulum. Synonym: cistern of nuclear envelope, perinuclear space. (05 Mar 2000) |
| proliferating cell nuclear antigen | Acidic nuclear protein (33 kD) highly expressed in dividing cells. Interacts with D type cyclins. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|